JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

metrics 2024

Empowering healthcare through groundbreaking findings.

Introduction

JAIDS - Journal of Acquired Immune Deficiency Syndromes, is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the dynamics of HIV/AIDS and its broader implications in the fields of infectious diseases and pharmacology. With an esteemed impact factor that places it in the prestigious Q1 category for both Infectious Diseases and Pharmacology (medical) as of 2023, this journal aims to provide a platform for groundbreaking research, clinical findings, and innovative therapies relevant to the management and prevention of HIV/AIDS. The journal's rigorous editorial standards and commitment to advancing knowledge make it an essential resource for researchers, healthcare professionals, and students invested in the global response to AIDS. Although the journal does not currently offer open access options, it remains instrumental in disseminating high-quality research that shapes clinical practices and policy developments in the field.

Metrics 2024

SCIMAGO Journal Rank1.23
Journal Impact Factor2.90
Journal Impact Factor (5 years)3.00
H-Index171
Journal IF Without Self2.90
Eigen Factor0.01
Normal Eigen Factor3.23
Influence1.30
Immediacy Index0.60
Cited Half Life7.80
Citing Half Life6.50
JCI0.60
Total Documents8188
WOS Total Citations11355
SCIMAGO Total Citations94099
SCIMAGO SELF Citations6933
Scopus Journal Rank1.23
Cites / Document (2 Years)2.70
Cites / Document (3 Years)2.82
Cites / Document (4 Years)2.85

Metrics History

Rank 2024

Scopus

Pharmacology (medical) in Medicine
Rank #84/272
Percentile 69.12
Quartile Q2
Infectious Diseases in Medicine
Rank #119/344
Percentile 65.41
Quartile Q2

IF (Web Of Science)

IMMUNOLOGY
Rank 108/181
Percentile 40.60
Quartile Q3
INFECTIOUS DISEASES
Rank 58/132
Percentile 56.40
Quartile Q2

JCI (Web Of Science)

IMMUNOLOGY
Rank 101/181
Percentile 44.20
Quartile Q3
INFECTIOUS DISEASES
Rank 64/132
Percentile 51.52
Quartile Q2

Quartile History

Similar Journals

AIDS Research and Treatment

Driving discovery in AIDS treatment.
Publisher: HINDAWI LTDISSN: 2090-1240Frequency: 1 issue/year

AIDS Research and Treatment is a premier open access journal published by HINDAWI LTD, dedicated to advancing the understanding and treatment of HIV/AIDS and related conditions. Launched in 2010, the journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of Dermatology, Immunology, Infectious Diseases, and Public Health. With a notable 2023 impact factor reflected in its Q2 and Q3 quartile rankings across key medical categories, the journal plays a critical role in disseminating high-quality research and fostering innovation in the prevention and treatment of AIDS. It provides a wide range of open access options, enabling easier dissemination and increased visibility of research findings globally. As the landscape of HIV/AIDS research continues to evolve, AIDS Research and Treatment remains at the forefront, ensuring crucial insights and developments are shared to enhance public health outcomes.

INTERNATIONAL JOURNAL OF STD & AIDS

Advancing knowledge in the fight against STDs and HIV/AIDS.
Publisher: SAGE PUBLICATIONS LTDISSN: 0956-4624Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF STD & AIDS is a prominent publication dedicated to advancing the understanding and treatment of sexually transmitted diseases and HIV/AIDS. Published by SAGE Publications Ltd, this esteemed journal has been contributing to the medical community since 1990, with a convergence of studies spanning to 2024. With its ISSN 0956-4624 and E-ISSN 1758-1052, the journal is recognized for its rigorous peer-reviewed research and has successfully positioned itself in the second quartile (Q2) of Dermatology and Public Health, alongside notable rankings in Infectious Diseases and Pharmacology. Currently based in the United Kingdom, this journal serves as a crucial resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and critical reviews that address global health challenges. Although it does not offer Open Access, the journal continues to maintain its reputation as a vital reference point for those invested in the fields of dermatology, public health, and infectious diseases.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Exploring innovative strategies for effective disease prevention.
Publisher: ELSEVIER SCIENCE INCISSN: 0749-3797Frequency: 12 issues/year

AMERICAN JOURNAL OF PREVENTIVE MEDICINE is a premier publication in the fields of Epidemiology and Public Health, published by Elsevier Science Inc. With a commendable impact factor and ranking within the top quartile for both Epidemiology and Public Health categories, this journal serves as a vital source of cutting-edge research, reviews, and critical insights aimed at promoting health and preventing disease. Since its inception in 1985, the journal has been dedicated to disseminating high-quality articles that inform health policy, improve clinical practices, and enhance community health initiatives. It is readily available to researchers and professionals committed to advancing their knowledge and practice, ensuring the continued evolution of preventive medicine. The journal's reach and influence, underscored by its impressive rankings, position it as an essential resource for those looking to make a meaningful impact in the world of preventive health.

Annals of Clinical Psychiatry

Empowering Practitioners with Evidence-Based Insights.
Publisher: QUADRANT HEALTHCOM INCISSN: 1040-1237Frequency: 4 issues/year

Annals of Clinical Psychiatry, published by QUADRANT HEALTHCOM INC, is a leading journal in the fields of Medicine and Psychiatry & Mental Health. With its longstanding commitment to advancing clinical knowledge since 1989, this esteemed journal contributes invaluable insights into current psychiatric practices and mental health research. The journal is recognized in the Scopus ranking with a position in the 34th percentile, reflective of its focused scope and substantial academic contributions. While access to the journal is tailored for professionals and researchers, the absence of Open Access highlights the journal's dedication to maintaining quality and rigorous peer-reviewed standards. As part of the Q3 quartile for both Medicine and Psychiatry categories in 2023, Annals of Clinical Psychiatry serves as an essential resource for those dedicated to improving mental health outcomes, making it a vital platform for practitioners, researchers, and students alike. Situated in Parsippany, New Jersey, the journal remains a pivotal entity that fosters scholarly dialogue and exploration in clinical psychiatry.

AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Exploring Innovative Solutions for Drug and Alcohol Challenges
Publisher: TAYLOR & FRANCIS INCISSN: 0095-2990Frequency: 6 issues/year

American Journal of Drug and Alcohol Abuse is a highly regarded publication in the field of substance abuse research, published by Taylor & Francis Inc. With its inception in 1974, this journal has become an essential resource for scholars and practitioners interested in clinical psychology, psychiatry, and the multifaceted issues surrounding drug and alcohol use. It holds a notable Q2 ranking in Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, emphasizing its impact and relevance in these domains. The journal's 2023 Scopus rankings further highlight its standing, placing it in the top quartile of publications with established readership and citation metrics. Researchers and students can benefit from its comprehensive articles that delve into the complexities of substance use, treatment methodologies, and the socio-psychological underpinnings of addiction. Whether you seek to access cutting-edge studies or contribute to ongoing discourse in the field, the American Journal of Drug and Alcohol Abuse serves as a vital hub for knowledge dissemination and scholarly engagement.

Preventive Medicine

Leading the charge in disease prevention and health promotion.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0091-7435Frequency: 12 issues/year

Preventive Medicine is a premier academic journal published by Academic Press Inc Elsevier Science, renowned for its influential contributions to the fields of Epidemiology and Public Health. Since its inception in 1946 and through its dedicated issues leading into 2024, the journal has established itself as a leading platform for cutting-edge research, boasting impressive Scopus rankings, with a notable Q1 status across relevant categories. This journal provides an essential forum for scholars, practitioners, and policy-makers interested in the prevention of diseases and the promotion of health within populations. With each issue, it disseminates valuable insights on preventive strategies, health behaviors, and epidemiological trends, making it crucial for anyone invested in the advancement of public health sciences. The journal does not offer open access options, ensuring that content remains relevant and targeted to its scholarly audience. Given its valuable contributions and recognition in the academic community, Preventive Medicine continues to play a pivotal role in shaping evidence-based approaches to health promotion and disease prevention in modern societal contexts.

Preventive Medicine Reports

Fostering knowledge exchange for a healthier global community.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Preventive Medicine Reports is a premier open-access journal published by Elsevier, dedicated to advancing the field of preventive medicine and public health. With a focus on innovative research and practices since its inception in 2014, this journal has established itself in the top quartile (Q1) of both Health Informatics and Public Health, Environmental and Occupational Health categories as of 2023. This positions it among the leading publications in its field, showcasing significant contributions to health informatics and public health strategies. The journal's accessibility allows researchers, professionals, and students worldwide to engage with cutting-edge studies that inform health policy and preventive initiatives. By fostering an open exchange of knowledge, Preventive Medicine Reports aims to reduce health disparities and improve population health outcomes, making it an essential resource for anyone invested in the future of health sciences.

JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE

Transforming Health Policy for Global Impact
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1078-4659Frequency: 6 issues/year

JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, published by Lippincott Williams & Wilkins, stands as a pivotal resource in the fields of Health Policy and Public Health. With an ISSN of 1078-4659 and an E-ISSN of 1550-5022, this journal has been disseminating high-quality research since its inception in 1995, serving a global audience from its base in the United States. Renowned for its contributions, it holds a respectable ranking within the Scopus database, positioned in the 55th percentile for both Public Health, Environmental and Occupational Health, and Health Policy. The journal’s focus is to provide a platform for scholarly articles that enhance the practice of public health management, making it an essential read for researchers, practitioners, and students alike. By fostering a community of informed professionals, the journal aims to bridge the gap between theory and practice, ensuring that advancements in public health are effectively addressed and disseminated.

Health Promotion and Chronic Disease Prevention in Canada-Research Policy and Practice

Advancing Canadian health through research and policy.
Publisher: PUBLIC HEALTH AGENCY CANADAISSN: 2368-738XFrequency: 4 issues/year

Health Promotion and Chronic Disease Prevention in Canada - Research Policy and Practice is a leading open-access journal published by the Public Health Agency Canada. This journal, indexed with the ISSN 2368-738X, is dedicated to advancing the field of health promotion while addressing chronic disease prevention in the Canadian context. Since its inception in 2008, it has gained a robust reputation, evidenced by its ranking in the second quartile (Q2) across multiple categories including Epidemiology, Health Policy, and Public Health, Environmental and Occupational Health. With its emphasis on research and policy implications, the journal serves as a critical resource for researchers, healthcare professionals, and students alike, aiming to promote evidence-based practices and driving discussions that shape public health policies. The journal is particularly noted for its triangulation of research findings into actionable strategies, making it relevant for both academic inquiry and practical application. Whether you are seeking to enhance your knowledge or contribute to the discourse on chronic disease prevention, this journal offers a platform for sharing impactful research and innovative ideas.

AJAR-African Journal of AIDS Research

Connecting Scholars, Shaping Public Health
Publisher: TAYLOR & FRANCIS LTDISSN: 1608-5906Frequency: 4 issues/year

AJAR - African Journal of AIDS Research, an esteemed publication by Taylor & Francis Ltd, stands at the forefront of research in the field of HIV/AIDS, with a specific focus on the African continent. Established in 2003 and publishing continuously through 2024, this journal serves as a crucial platform for disseminating innovative research findings aimed at addressing the challenges of HIV/AIDS. With its ISSN 1608-5906 and E-ISSN 1727-9445, AJAR is indexed in prominent databases and holds a respectable Q3 rating in major categories such as Infectious Diseases, Medicine, Public Health, and Virology as of 2023. This positions the journal as a relevant resource for scholars and medical professionals looking to stay informed on the latest developments and strategies in AIDS research. Although it is not currently an open-access journal, AJAR provides readers with valuable insights that are essential for advancing public health initiatives and infectious disease research across Africa and beyond. The journal's commitment to high-quality peer-reviewed research underscores its importance within its field, making it a vital resource for researchers, students, and policymakers alike.